ID
33379
Descrição
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains the Concomitant Medications form. It has to be filled in if concomitant medications were taken by subject during study.
Link
https://clinicaltrials.gov/ct2/show/NCT00599612
Palavras-chave
Versões (3)
- 04/12/2018 04/12/2018 -
- 07/12/2018 07/12/2018 -
- 10/12/2018 10/12/2018 - Sarah Riepenhausen
Titular dos direitos
GlaxoSmithKline
Transferido a
7 de dezembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Concomitant Medications
- StudyEvent: ODM
Similar models
Concomitant Medications
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])